QR-Code

From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors

Aromatase inhibitors (AI) are extensively used as adjuvant endocrine therapy in post-menopausal women with hormone receptor-positive early breast cancer (HR+ EBC), but their impact on bone health is not negligible. This work aimed to assess bone loss, fracture incidence, and risk factors associated...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Leonor Vasconcelos de Matos, Leonor Fernandes, Maria Teresa Neves, Fátima Alves, Mafalda Baleiras, André Ferreira, Pedro Giesteira Cotovio, Tiago Dias Domingues, Mariana Malheiro, Ana Plácido, Maria Helena Miranda, Ana Martins
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2021-02-01
Schriftenreihe:Current Oncology
Schlagworte:
breast cancer
aromatase inhibitors
osteoporosis
fracture
Online-Zugang:https://www.mdpi.com/1718-7729/28/2/104
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge